76 related articles for article (PubMed ID: 17624914)
1. Fluoxetine vs placebo for depressive symptoms after stroke: failed randomised controlled trial.
Ruddell M; Spencer A; Hill K; House A
Int J Geriatr Psychiatry; 2007 Oct; 22(10):963-5. PubMed ID: 17624914
[TBL] [Abstract][Full Text] [Related]
2. A controlled trial of fluoxetine in nondepressed patients with Huntington's disease.
Como PG; Rubin AJ; O'Brien CF; Lawler K; Hickey C; Rubin AE; Henderson R; McDermott MP; McDermott M; Steinberg K; Shoulson I
Mov Disord; 1997 May; 12(3):397-401. PubMed ID: 9159735
[TBL] [Abstract][Full Text] [Related]
3. Treatment of depressive symptoms in patients with early stage breast cancer undergoing adjuvant therapy.
Navari RM; Brenner MC; Wilson MN
Breast Cancer Res Treat; 2008 Nov; 112(1):197-201. PubMed ID: 18064563
[TBL] [Abstract][Full Text] [Related]
4. Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine.
Honig A; Kuyper AM; Schene AH; van Melle JP; de Jonge P; Tulner DM; Schins A; Crijns HJ; Kuijpers PM; Vossen H; Lousberg R; Ormel J;
Psychosom Med; 2007; 69(7):606-13. PubMed ID: 17846258
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder.
Garakani A; Martinez JM; Marcus S; Weaver J; Rickels K; Fava M; Hirschowitz J
Int Clin Psychopharmacol; 2008 Sep; 23(5):269-75. PubMed ID: 18703936
[TBL] [Abstract][Full Text] [Related]
6. Fluoxetine for the prophylaxis of poststroke depression in patients with stroke: a meta-analysis.
Yi ZM; Liu F; Zhai SD
Int J Clin Pract; 2010 Aug; 64(9):1310-7. PubMed ID: 20653802
[TBL] [Abstract][Full Text] [Related]
7. Prescribing antidepressants to advanced cancer patients with mild depressive symptoms is not justified.
Coyne JC; Palmer SC; Shapiro PJ
J Clin Oncol; 2004 Jan; 22(1):205-6; author reply 206-8. PubMed ID: 14701791
[No Abstract] [Full Text] [Related]
8. Is psychotherapy a reliable alternative to pharmacotherapy to promote the mental health of infertile women? A randomized clinical trial.
Faramarzi M; Kheirkhah F; Esmaelzadeh S; Alipour A; Hjiahmadi M; Rahnama J
Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):49-53. PubMed ID: 18848381
[TBL] [Abstract][Full Text] [Related]
9. Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trial.
Bretlau LG; Lunde M; Lindberg L; Undén M; Dissing S; Bech P
Pharmacopsychiatry; 2008 Mar; 41(2):41-7. PubMed ID: 18311683
[TBL] [Abstract][Full Text] [Related]
10. Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder.
Papakostas GI; McGrath P; Stewart J; Charles D; Chen Y; Mischoulon D; Dording C; Fava M
Psychiatry Res; 2008 Oct; 161(1):116-20. PubMed ID: 18755514
[TBL] [Abstract][Full Text] [Related]
11. Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome.
Vercoulen JH; Swanink CM; Zitman FG; Vreden SG; Hoofs MP; Fennis JF; Galama JM; van der Meer JW; Bleijenberg G
Lancet; 1996 Mar; 347(9005):858-61. PubMed ID: 8622391
[TBL] [Abstract][Full Text] [Related]
12. Clinician, parent, and child prediction of medication or placebo in double-blind depression study.
Hughes CW; Emslie G; Kowatch R; Weinberg W; Rintelmann J; Rush AJ
Neuropsychopharmacology; 2000 Nov; 23(5):591-4. PubMed ID: 11027925
[TBL] [Abstract][Full Text] [Related]
13. Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial.
van Kerkhoven LA; Laheij RJ; Aparicio N; De Boer WA; Van den Hazel S; Tan AC; Witteman BJ; Jansen JB
Clin Gastroenterol Hepatol; 2008 Jul; 6(7):746-52; quiz 718. PubMed ID: 18424191
[TBL] [Abstract][Full Text] [Related]
14. Treatment of depression and anxiety in infertile women: cognitive behavioral therapy versus fluoxetine.
Faramarzi M; Alipor A; Esmaelzadeh S; Kheirkhah F; Poladi K; Pash H
J Affect Disord; 2008 May; 108(1-2):159-64. PubMed ID: 17936366
[TBL] [Abstract][Full Text] [Related]
15. Divalproex versus placebo for the prevention of irritability associated with fluoxetine treatment in autism spectrum disorder.
Anagnostou E; Esposito K; Soorya L; Chaplin W; Wasserman S; Hollander E
J Clin Psychopharmacol; 2006 Aug; 26(4):444-6. PubMed ID: 16855475
[No Abstract] [Full Text] [Related]
16. Placebo-controlled treatment trial of depression in elderly physically ill patients.
Evans M; Hammond M; Wilson K; Lye M; Copeland J
Int J Geriatr Psychiatry; 1997 Aug; 12(8):817-24. PubMed ID: 9283926
[TBL] [Abstract][Full Text] [Related]
17. Fluoxetine versus placebo for the marijuana use of depressed alcoholics.
Cornelius JR; Salloum IM; Haskett RF; Ehler JG; Jarrett PJ; Thase ME; Perel JM
Addict Behav; 1999; 24(1):111-4. PubMed ID: 10189977
[TBL] [Abstract][Full Text] [Related]
18. Fluoxetine and imipramine: are there differences in cost-utility for depression in primary care?
Serrano-Blanco A; Suárez D; Pinto-Meza A; Peñarrubia MT; Haro JM;
J Eval Clin Pract; 2009 Feb; 15(1):195-203. PubMed ID: 19239602
[TBL] [Abstract][Full Text] [Related]
19. Fluoxetine (prozac) in depresion of adults.
Kocur J; Rydzynski Z; Duszyk S; Gruszczynski W; Trendak W
Homeost Health Dis; 1991; 33(5-6):295. PubMed ID: 18265505
[No Abstract] [Full Text] [Related]
20. [Seizures crisis following sudden stop of fluoxetine].
Epelde F; Plà R; Aguilar M
Med Clin (Barc); 1999 Oct; 113(12):479. PubMed ID: 10570524
[No Abstract] [Full Text] [Related]
[Next] [New Search]
